Navigation Links
Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials
Date:11/19/2009

siRNA by advancing its clinical-stage programs, and our momentum is accelerating as we enrich the Company's pipeline and bring more product candidates into the clinic," said Daniel Zurr, Ph.D., President and Chief Executive Officer of Quark Pharmaceuticals. "Over the next 15 months, we anticipate at least one program may proceed into Phase 3 registration studies, we will report data from multiple clinical studies and we plan to file our fifth IND. We have demonstrated we have the right team and the right strategy, and we are excited about the Company's future."

Dr. Shai Erlich, Quark's Chief Medical Officer, stated, "Quark's discovery and development efforts remain focused on the goal of bringing novel and clinically relevant therapeutic options to health care providers. We do this by addressing molecular pathways that previously were not accessible to more traditional forms of pharmaceutical modulation. Quark is generating novel siRNA drug candidates and is pursuing a variety of delivery mechanisms to expand the scope of potential disease applications while eliminating the need to depend on extensive drug modifications and elaborate formulations that could reduce the therapeutic index for patients. To date, preliminary results from Quark's Phase 1 clinical studies have shown few adverse drug reactions and no treatment emergent dose-limiting toxicities. I look forward to the next stage when the company reports completed study results findings in a range of disease indications."

About Quark Pharmaceuticals, Inc.

Quark Pharmaceuticals, Inc., is a leader in the discovery and development of novel therapeutic RNAi drug candidates. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development. The Company's technology platform includes novel disease targets and siRNA structures and chemistry, providing Quark with freedom to operate in the siRNA intellectual property ar
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases
2. Quark Pharmaceuticals Expands International Patent Protection for Compounds Targeting the RTP801 Gene
3. Quark Pharmaceuticals Presents at Asia TIDES Conference
4. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
5. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
6. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
7. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
10. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
11. Quark Pharmaceuticals Appoints New Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... -- A recently published clinical study conducted at TOPS Comprehensive ... demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary ... The study, "Implementation of Breast Tomosynthesis in a Routine ... Stephen L. Rose , MD, and published ... of Roentgenology (AJR). The AJR is the scientific ...
(Date:5/23/2013)... Anthem Blue Cross patients with HIV/AIDS may ... to obtain their medications by mail order under a ... LLC.  The lawsuit, filed in January ... mandatory mail order program announced late last year illegally ... "This settlement brings to a close a nerve-racking ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... George Products Company, Inc. has announced the addition ... OASIS Inspection Systems. Florida Metrology, based ... OASIS Inspection Systems is a line of highly accurate ... control departments across the United States. Tim Row of ...
... Sutro Biopharma, a biopharmaceutical company developing both ... properties, today announced that it has appointed Trevor ... Hallam will lead Sutro,s ongoing efforts in the ... platform for the research and development of novel ...
Cached Medicine Technology:Florida Metrology To Distribute OASIS Inspection Systems 2Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2
(Date:5/24/2013)... California (PRWEB) May 24, 2013 Residents ... comes to boot camp classes. Fitness expert, and Certified ... series of Kettlebell X Bootcamps in San Diego, California. ... variety of different class times offered. Initial sign-ups ... , “I’ve been teaching Kettlebell for years. ...
(Date:5/24/2013)... DiscountHumidifiers.com, an eCommerce store specializing in economical humidification ... line of humidifiers. These tastefully designed humidifiers are ... styles to choose from. , The ... piece – yet its functionality is not easily recognized. ... an inconspicuous humidifying appliance. With the built-in aroma diffuser, ...
(Date:5/24/2013)... Impacts World 2013 from May 27-30th brings together ... and civil society to discuss a new vision ... and scales. , Webcast of opening press conference ... to 1:55pm and opening plenary from 2pm: ... Connie Hedegaard, EU Commissioner for Climate Action, Joseph ...
(Date:5/24/2013)... NY (PRWEB) May 24, 2013 The ... Cellular Dynamics International (CDI) exclusive license rights to ... and regenerative medicine applications. These cells are capable of ... heart, including cardiomyocytes, endothelial cells, and vascular smooth muscle ... therapeutic for damaged heart tissue. , The original agreement ...
(Date:5/24/2013)... Certain statins -- the widely used cholesterol-lowering drugs ... 2 diabetes, a new study suggests. The ... name Lipitor), rosuvastatin (Crestor) and simvastatin (Zocor), the ... Ontario residents, researchers in Canada found that the ... patients prescribed statins. Still, people taking Lipitor had ...
Breaking Medicine News(10 mins):Health News:DiscountHumidifiers.com Announces the Launch of the New Broksonic Humidifiers to their Online Store 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:Could Statins Raise Diabetes Risk? 2Health News:Could Statins Raise Diabetes Risk? 3
... , Project Bread addresses ... , BOSTON, Nov. 20 Project Bread, the state,s leading ... on hunger in the Commonwealth. The disquieting trends described in ... in the Commonwealth struggling with hunger. Food insecurity has found ...
... , MOUNTAIN VIEW, Calif., Nov. 20 Omnicell, Inc. ... healthcare facilities, announced today the company will present at the 21st ... New York, NY. , Omnicell Speakers: Randall A. ... CFO , Date: Tuesday, December 1, 2009 , Time: ...
... , , BATON ROUGE, La., Nov. 20 ... (LAHP) today warned that Louisianians could experience higher health care ... should become law. , According to Gil Dupre, chief executive ... care reform since the beginning of the national debate. ...
... , WASHINGTON, Nov. 20 The Senate,s newly ... infringes on Americans, health-insurance choices and medical privacy, says ... (IHF) -- a patients, rights group in Washington, D.C. ... , Require nearly every legal resident to buy ...
... , MARINA DEL REY, Calif., Nov. 20 Heritage Provider Network, ... as of November 6, 2009, Lakeside Medical Systems, Inc., as well ... Organization, part of the HPN family. , "We first and foremost ... HPN family are dedicated to maintaining the high level of care ...
... 20 Fear about the risk of surgery is among ... valve replacement surgery, according to a study by physicians at ... year, former First Lady Barbara Bush and comedian Robin Williams ... missing out on the potentially life-saving surgery. , In the ...
Cached Medicine News:Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:Congressional Health Care Reform Proposals Would Make Health Care More Expensive, Reduce Benefits for Louisianians 2Health News:Senate Mandatory Health-Insurance Bill Infringes on Choice and Privacy 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 2Health News:Heritage Provider Network CEO Dr. Richard Merkin, Announces the Acquisition of Lakeside Medical Systems, Inc. 3Health News:Half of Eligible Patients Do Not Get Aortic Valve Replacement 2
... Stand Magnifier offers versatility across a ... lens and the light are adjustable. ... hand held objects can be worked ... parallel to the work surface, lay ...
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
... Central platform with integrated neck. Piston ... an internal spring to recoil to ready ... precision milled cavity in platform. Accepts disposable ... Designed for the use in in the ...
... TLS Surgical Markers allows ... incision sites with a scrub-resistant, ... Surgical Markers are provided sterile, ... individually packaged in peel pouches. ...
Medicine Products: